Table 2 6 month infant weight and anthropometric outcomes by treatment group

From: Effects of an antenatal dietary intervention in overweight and obese women on 6 month infant outcomes: follow-up from the LIMIT randomised trial

Outcome

Lifestyle advice (N = 1071)

Standard Care (N = 1065)

Unadjusted treatment effect (95% CI)

Unadjusted P-value

Adjusted treatment effect (95% CI)

Adjusted P-value

BMI z-score ≥90th centile*

233 (21.71)

233 (21.90)

0.99 (0.83, 1.19)

0.927

0.99 (0.82, 1.18)

0.882

BMI z-score ≥85th centile*

299 (27.88)

303 (28.48)

0.98 (0.84, 1.14)

0.783

0.97 (0.84, 1.13)

0.713

BMI

17.68 (1.82)

17.70 (1.79)

−0.01 (−0.18, 0.16)

0.873

−0.02 (−0.19, 0.15)

0.824

BMI z-score

0.37 (1.17)

0.38 (1.16)

−0.01 (−0.12, 0.10)

0.860

−0.01 (−0.12, 0.09)

0.792

Weight (kg)

8.26 (1.33)

8.29 (1.33)

−0.03 (−0.15, 0.09)

0.619

−0.05 (−0.16, 0.06)

0.376

Weight z-score

0.30 (1.13)

0.34 (1.11)

−0.04 (−0.14, 0.06)

0.453

−0.04 (−0.14, 0.06)

0.426

Length (cm)

68.24 (3.76)

68.28 (4.13)

−0.05 (−0.41, 0.31)

0.793

−0.12 (−0.41, 0.16)

0.407

Length z-score

0.06 (1.22)

0.11 (1.28)

−0.05 (−0.16, 0.07)

0.444

−0.04 (−0.16, 0.07)

0.463

Weight-Length Ratio

0.12 (0.01)

0.12 (0.01)

−0.00 (−0.00, 0.00)

0.881

−0.00 (−0.00, 0.00)

0.718

Weight-Length Ratio z-score

0.44 (1.18)

0.48 (1.14)

−0.03 (−0.14, 0.07)

0.525

−0.04 (−0.15, 0.07)

0.466

Head circumference (cm)

43.83 (1.77)

43.79 (1.88)

0.04 (−0.13, 0.21)

0.655

0.03 (−0.12, 0.18)

0.698

Head circumference z-score

0.45 (1.08)

0.43 (1.13)

0.02 (−0.08, 0.12)

0.684

0.03 (−0.08, 0.13)

0.602

Chest circumference (cm)

44.45 (2.77)

44.51 (2.75)

−0.06 (−0.33, 0.21)

0.677

−0.09 (−0.35, 0.17)

0.485

Abdominal circumference (cm)

44.53 (3.79)

44.35 (3.76)

0.18 (−0.19, 0.55)

0.346

0.16 (−0.20, 0.52)

0.392

Arm circumference (cm)

14.97 (1.31)

14.95 (1.34)

0.02 (−0.11, 0.15)

0.776

0.01 (−0.11, 0.14)

0.841

Biceps SFTM (mm)

6.47 (2.00)

6.34 (2.00)

0.13 (−0.09, 0.35)

0.257

0.12 (−0.10, 0.34)

0.275

Triceps SFTM (mm)

10.03 (2.53)

10.24 (2.52)

−0.21 (−0.49, 0.06)

0.129

−0.22 (−0.50, 0.06)

0.120

Subscapular SFTM (mm)

6.94 (1.81)

6.93 (1.87)

0.02 (−0.18, 0.22)

0.881

0.01 (−0.19, 0.21)

0.936

Supra-iliac SFTM (mm)

11.50 (4.91)

11.34 (5.13)

0.16 (−0.37, 0.69)

0.547

0.14 (−0.38, 0.66)

0.600

Abdominal SFTM (mm)

7.81 (2.39)

7.89 (2.39)

−0.08 (−0.33, 0.17)

0.543

−0.09 (−0.33, 0.16)

0.492

Thigh SFTM (mm)

18.43 (4.58)

18.32 (4.17)

0.11 (−0.37, 0.59)

0.642

0.08 (−0.39, 0.56)

0.725

Sum of SFTM (mm)

60.79 (12.61)

60.50 (12.68)

0.30 (−0.96, 1.56)

0.644

0.25 (−1.01, 1.50)

0.703

  1. Values for continuous outcomes are mean and standard deviation and treatment effects are differences in means. Values for binary outcomes (*) are number and percentage and treatment effects are relative risks. All estimates are based on imputed data including all infants who were eligible for the follow-up study.
  2. Adjusted analyses included the stratification variables BMI category, parity and centre, as well as maternal age, socioeconomic status and maternal smoking. Non z-score outcomes were additionally adjusted for actual age at assessment and infant gender.
Back to article page